)
Visual
test
LeonaBio
LeonaBio (LONA) investor relations material
LeonaBio Proxy Filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy Filing summary4 Feb, 2026
Executive summary
Special Meeting scheduled for March 18, 2026, to be held virtually for shareholder participation and voting.
Six key proposals will be presented, including share issuances, equity plan approval, and charter amendment.
Board recommends voting in favor of all proposals to support corporate transactions and future flexibility.
Voting matters and shareholder proposals
Proposal 1: Approve issuance of 5,502,402 shares upon exercise of a pre-funded warrant to Sermonix Pharmaceuticals, subject to Nasdaq Rule 5635(a)(2).
Proposal 2: Approve issuance of shares to Sermonix if it would own over 19.99% of outstanding stock, per Nasdaq Rule 5635(b).
Proposal 3: Approve issuance of shares to Perceptive Advisors if it would own over 19.99% of outstanding stock, per Nasdaq Rule 5635(b).
Proposal 4: Approve the 2026 Equity Incentive Plan, replacing the 2020 plan.
Proposal 5: Amend certificate of incorporation to increase authorized common stock from 90M to 400M shares.
Proposal 6: Approve adjournment of the meeting if more time is needed to solicit votes.
Board of directors and corporate governance
Board recommends voting “FOR” all proposals and has engaged a proxy solicitation firm for the meeting.
PIPE Financing agreement entitles certain investors to board representation if they hold 5% or more of shares.
Board has adopted and periodically updated an outside director compensation policy, with annual and initial equity awards.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- TMCV
Q2 FY26 delivered double-digit margin growth, record cash flow, and strong market momentum. - DANSKE
Record profit, strong credit quality, and 100% payout; 2026 outlook remains positive. - GREENPLY
Q3 FY26 delivered strong revenue growth but lower profit, with major MDF expansion announced. - KRO
Q1 2025 net income surged to $18.1M on higher TiO2 sales, improved margins, and LPC integration. - WALL
Profit after tax more than tripled to SEK 2,564 million, with net asset value per share up 8%. - TMCVQ3 FY26 delivered 17% revenue growth, 12.7% EBITDA margin, and strong cash flow.
- SHL
Imaging and therapy growth drove 3.8% Q1 revenue; 2026 outlook and EPS guidance confirmed. - SAAB
Record order backlog and double-digit growth across all segments fueled strong 2025 results. - KROQ3 2025 net loss of $37M reflects lower TiO2 prices, weak demand, and higher costs.
- YATHARTH
Strong revenue and profit growth, major capital deployment, and new hospital acquisition mark the quarter.
Next LeonaBio earnings date
Q4 202520 Feb, 2026
LeonaBio
Next LeonaBio earnings date
Q4 202520 Feb, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Athira Pharma Inc., also known as Athira Pharma, is a late clinical-stage biopharmaceutical company focused on developing small molecules aimed at restoring neuronal health and slowing neurodegeneration. The company's leading product candidate, ATH-1017 (Fosgonimeton), is designed to enhance the activity of the hepatocyte growth factor (HGF) and its receptor, MET. The company is headquartered in Bothell, Washington, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage